Different from other IL-6 family members, IL-11 administration reduces inflammatory responses in chronic inflammatory diseases, lipopolysaccharide-induced sepsis, macrophages inflammation, nephrotoxic nephritis and T-cell mediated liver injury [9–11]. This evidence concerns the gene IL6 and Sepsis.